Featured
Webinars
Building confidence for regulatory decision-making with immune competent models
Webinar Series 9 Episode 2
Discover how human liver models are building regulatory confidence in DILI risk assessment. How a continuously perfused, primary human Liver model, with immune-competent capabilities, can be leveraged to address a critical unmet need — capturing immune mediated toxicities associated with new drug modalities such as monoclonal antibodies (mAbs).
Read More Webinars
Building better data packages: The role of MPS in modern efficacy, toxicity and ADME workflows
Technology Network: Organoids and Microphysiological Systems Symposium 2026
Explores how MPS can be integrated into modern drug discovery workflows alongside other in vitro, in vivo and in silico tools to generate more predictive, human‑relevant data, improving translational confidence and informing decision making.
Read More Blogs
Integrating In Silico Tools with Organ-on-a-Chip to advance ADME studies
Knowing a drug’s bioavailability during lead optimization is crucial as it directly influences dosing strategy, therapeutic efficacy, safety margins, and formulation design.
Read MoreFilters
Videos and animations
How to Scale Organ-on-a-Chip
Blogs
Cancer-on-a-chip melanoma model for CAR T cell therapy development in solid tumors
Videos and animations
How to Collect Tissue Samples from Organ-on-a-Chip Experiments
Videos and animations
How to Perform Endpoint Media Recovery for Analysis from Organ-on-a-Chip
Videos and animations
How to Dose Your Organ on a Chip Tissue
Videos and animations
How to Seed Cells for Organ-on-a-Chip Experiments
Infographic
A visual guide to improving oral bioavailability prediction
Podcasts
How Do We Build Better Medicines Without Relying on Animal Testing
Case studies
How Pharmaron is advancing DMPK and toxicology studies with human-relevant MPS
Videos and animations
How to Set Up an Organ-on-a-Chip System
Scientific publications
Introduction to the 3RsC’s cross-platform microphysiological systems evaluation for drug-induced liver injury in collaboration with FDA-CDER
Articles